The Dominion Diamond Corp (DDC) Given a $10.00 Price Target at RBC Capital Markets

DDC has been the topic of a number of other research reports. TD Securities reissued a buy rating and issued a $18.00 price objective (down previously from $19.00) on shares of Dominion Diamond Corp in a research note on Thursday, December 15th. Zacks Investment Research raised Dominion Diamond Corp from a sell rating to a hold rating in a research note on Tuesday, November 22nd. TheStreet raised Dominion Diamond Corp from a sell rating to a hold rating in a research note on Thursday, December 15th. Scotiabank reissued an outperform rating and issued a $14.00 price objective on shares of Dominion Diamond Corp in a research note on Tuesday, December 6th. Finally, BMO Capital Markets set a $18.00 price objective on Dominion Diamond Corp and gave the stock a buy rating in a research note on Saturday, November 19th. Four equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The stock currently has a consensus rating of Buy and a consensus price target of $13.73.

RBC Capital Markets set a $10.00 target price on Dominion Diamond Corp (NYSE:DDC) (TSE:DDC) in a report published on Thursday. The brokerage currently has a hold rating on the stock.

Shares of Dominion Diamond Corp (NYSE:DDC) traded down 1.00% during mid-day trading on Thursday, reaching $8.91. The company’s stock had a trading volume of 153,663 shares. The firm’s 50 day moving average is $10.07 and its 200-day moving average is $9.32. The company’s market capitalization is $740.02 million. Dominion Diamond Corp has a 52-week low of $7.92 and a 52-week high of $12.65.

Large investors have recently made changes to their positions in the company. Stanley Laman Group Ltd. bought a new stake in shares of Dominion Diamond Corp during the third quarter worth about $111,000. Sterling Capital Management LLC bought a new stake in shares of Dominion Diamond Corp during the second quarter worth about $118,000. Legal & General Group Plc raised its stake in shares of Dominion Diamond Corp by 103.5% in the second quarter. Legal & General Group Plc now owns 16,848 shares of the company’s stock worth $148,000 after buying an additional 8,568 shares during the period. A.R.T. Advisors LLC bought a new stake in shares of Dominion Diamond Corp during the fourth quarter worth about $191,000. Finally, Bessemer Group Inc. raised its stake in shares of Dominion Diamond Corp by 13.7% in the fourth quarter. Bessemer Group Inc. now owns 21,255 shares of the company’s stock worth $206,000 after buying an additional 2,560 shares during the period. 41.04% of the stock is currently owned by institutional investors.

Dominion Diamond Corp Company Profile

Dominion Diamond Corp is a diamond mining company. The Company is focused on the mining and marketing of rough diamonds to the global market. The Company’s segments include the Ekati Diamond Mine, the Diavik Diamond Mine and the Corporate segment. It supplies rough diamonds to the global market from its operation of the Ekati Diamond Mine (in which it owns a controlling interest) and its approximately 40% ownership interest in the Diavik Diamond Mine.

The Boston Scientific’s (BSX) Hold Rating Reaffirmed at Oppenheimer Holdings, Inc.

Other analysts have also issued research reports about the company. TheStreet raised Boston Scientific from a c+ rating to a b rating in a research note on Tuesday, January 17th. Needham & Company LLC reissued a buy rating and issued a $29.00 price target on shares of Boston Scientific in a research note on Thursday. BTIG Research reissued a hold rating on shares of Boston Scientific in a research note on Sunday, February 5th. Jefferies Group LLC reissued a hold rating and issued a $26.00 price target on shares of Boston Scientific in a research note on Friday, February 3rd. Finally, Zacks Investment Research lowered Boston Scientific from a buy rating to a hold rating in a research note on Monday, October 31st. Six analysts have rated the stock with a hold rating, twenty have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The company has an average rating of Buy and a consensus price target of $25.88.

Oppenheimer Holdings, Inc. reaffirmed their hold rating on shares of Boston Scientific Co. (NYSE:BSX) in a research report released on Thursday morning.

Shares of Boston Scientific (NYSE:BSX) traded up 0.960% during trading on Thursday, hitting $24.715. The stock had a trading volume of 8,088,948 shares. The company has a market cap of $33.66 billion, a P/E ratio of 98.860 and a beta of 1.06. Boston Scientific has a one year low of $16.82 and a one year high of $25.65. The stock’s 50-day moving average price is $24.24 and its 200-day moving average price is $22.99.

Boston Scientific (NYSE:BSX) last posted its quarterly earnings data on Thursday, February 2nd. The company reported $0.30 EPS for the quarter, beating analysts’ consensus estimates of $0.29 by $0.01. The business had revenue of $2.19 billion for the quarter, compared to analyst estimates of $2.16 billion. Boston Scientific had a return on equity of 23.70% and a net margin of 4.14%. The business’s revenue for the quarter was up 10.8% compared to the same quarter last year. During the same quarter last year, the company earned $0.26 earnings per share. On average, equities research analysts forecast that Boston Scientific will post $1.25 EPS for the current fiscal year.

In related news, EVP Timothy A. Pratt sold 6,195 shares of the firm’s stock in a transaction dated Monday, January 9th. The stock was sold at an average price of $22.24, for a total transaction of $137,776.80. Following the sale, the executive vice president now directly owns 231,273 shares in the company, valued at approximately $5,143,511.52. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, EVP Timothy A. Pratt sold 26,726 shares of the firm’s stock in a transaction dated Thursday, December 1st. The shares were sold at an average price of $20.48, for a total value of $547,348.48. Following the sale, the executive vice president now owns 260,430 shares in the company, valued at $5,333,606.40. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 123,936 shares of company stock worth $2,949,224. Company insiders own 1.31% of the company’s stock.

Several large investors have recently made changes to their positions in BSX. Trust Co. of Vermont increased its stake in shares of Boston Scientific by 2,298.3% in the third quarter. Trust Co. of Vermont now owns 4,221 shares of the company’s stock valued at $100,000 after buying an additional 4,045 shares during the last quarter. Tower Research Capital LLC TRC bought a new stake in shares of Boston Scientific during the third quarter valued at approximately $101,000. Synovus Financial Corp bought a new stake in shares of Boston Scientific during the third quarter valued at approximately $102,000. Bronfman E.L. Rothschild L.P. increased its stake in shares of Boston Scientific by 1.5% in the third quarter. Bronfman E.L. Rothschild L.P. now owns 4,511 shares of the company’s stock valued at $107,000 after buying an additional 66 shares during the last quarter. Finally, Gemmer Asset Management LLC increased its stake in shares of Boston Scientific by 2.4% in the third quarter. Gemmer Asset Management LLC now owns 4,991 shares of the company’s stock valued at $119,000 after buying an additional 119 shares during the last quarter. Institutional investors and hedge funds own 91.70% of the company’s stock.

Boston Scientific Company Profile

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven core businesses: Interventional Cardiology, Peripheral Interventions (PI), Cardiac Rhythm Management (CRM), Electrophysiology (EP), Endoscopy, Urology and Pelvic Health, and Neuromodulation.

The Cpcm LLC Takes Position in S&P Global Inc. (SPGI)

Other institutional investors also recently added to or reduced their stakes in the company. Artisan Partners Limited Partnership bought a new position in S&P Global during the second quarter worth about $837,221,000. BlackRock Institutional Trust Company N.A. bought a new position in S&P Global during the second quarter worth about $730,970,000. Edgewood Management LLC bought a new position in S&P Global during the second quarter worth about $640,341,000. Egerton Capital UK LLP bought a new position in S&P Global during the second quarter worth about $611,391,000. Finally, Ameriprise Financial Inc. bought a new position in S&P Global during the second quarter worth about $585,047,000. Institutional investors and hedge funds own 86.33% of the company’s stock.

Cpcm LLC purchased a new position in shares of S&P Global Inc. (NYSE:SPGI) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 1,973 shares of the company’s stock, valued at approximately $212,000.

Shares of S&P Global Inc. (NYSE:SPGI) traded down 0.36% during trading on Friday, hitting $130.31. The stock had a trading volume of 408,587 shares. The firm has a market cap of $33.67 billion, a PE ratio of 16.41 and a beta of 1.49. The stock has a 50 day moving average of $120.75 and a 200 day moving average of $120.66. S&P Global Inc. has a 52-week low of $88.75 and a 52-week high of $131.26.

S&P Global (NYSE:SPGI) last released its quarterly earnings results on Tuesday, February 7th. The company reported $1.28 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.19 by $0.09. S&P Global had a net margin of 37.20% and a return on equity of 297.85%. The company earned $1.40 billion during the quarter, compared to the consensus estimate of $1.34 billion. During the same period in the prior year, the firm earned $0.91 earnings per share. S&P Global’s revenue was up 1.8% on a year-over-year basis. On average, equities analysts anticipate that S&P Global Inc. will post $6.02 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Friday, March 10th. Investors of record on Friday, February 24th will be paid a $0.41 dividend. This is an increase from S&P Global’s previous quarterly dividend of $0.36. This represents a $1.64 dividend on an annualized basis and a yield of 1.25%. The ex-dividend date of this dividend is Wednesday, February 22nd. S&P Global’s dividend payout ratio is presently 18.11%.

SPGI has been the subject of a number of analyst reports. Zacks Investment Research downgraded S&P Global from a “buy” rating to a “hold” rating in a research note on Tuesday, November 15th. Piper Jaffray Companies restated an “overweight” rating and issued a $160.00 target price (up previously from $137.00) on shares of S&P Global in a research note on Thursday, February 9th. Credit Suisse Group restated an “outperform” rating and issued a $131.00 target price on shares of S&P Global in a research note on Sunday, November 20th. Cantor Fitzgerald set a $139.00 target price on S&P Global and gave the stock a “buy” rating in a research note on Tuesday, February 7th. Finally, Barclays PLC restated an “overweight” rating and issued a $140.00 target price (up previously from $130.00) on shares of S&P Global in a research note on Thursday, February 9th. One investment analyst has rated the stock with a hold rating and seven have given a buy rating to the company. S&P Global presently has an average rating of “Buy” and a consensus target price of $137.50.

In related news, Director Maria R. Morris purchased 400 shares of the firm’s stock in a transaction that occurred on Monday, January 23rd. The stock was bought at an average cost of $115.90 per share, with a total value of $46,360.00. Following the completion of the purchase, the director now directly owns 400 shares in the company, valued at $46,360. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Courtney Geduldig sold 3,724 shares of the stock in a transaction dated Wednesday, February 8th. The stock was sold at an average price of $124.97, for a total transaction of $465,388.28. Following the completion of the transaction, the executive vice president now directly owns 5,541 shares of the company’s stock, valued at $692,458.77. The disclosure for this sale can be found here. 0.60% of the stock is owned by corporate insiders.

S&P Global Company Profile

S&P Global Inc, formerly McGraw Hill Financial, Inc, is a provider of transparent and independent ratings, benchmarks, analytics and data to the capital and commodity markets across the world. The Company’s products cater to the capital markets, which includes asset managers, investment banks, commercial banks, exchanges and issuers; the commodities markets, which includes producers, traders and intermediaries within energy, metals, petrochemicals and agriculture, and the commercial markets, which includes professionals and corporate executives within automotive and marketing/research information services.

Want to see what other hedge funds are holding SPGI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for S&P Global Inc. (NYSE:SPGI).

The 7,448 Shares in Brunswick Corporation (BC) Acquired by Flinton Capital Management LLC

Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. New England Research & Management Inc. bought a new position in Brunswick Corporation during the third quarter worth approximately $268,000. Picton Mahoney Asset Management bought a new position in Brunswick Corporation during the third quarter worth approximately $278,000. LS Investment Advisors LLC increased its position in Brunswick Corporation by 5.6% in the third quarter. LS Investment Advisors LLC now owns 5,843 shares of the company’s stock worth $285,000 after buying an additional 311 shares in the last quarter. World Asset Management Inc increased its position in Brunswick Corporation by 32.4% in the third quarter. World Asset Management Inc now owns 5,880 shares of the company’s stock worth $287,000 after buying an additional 1,439 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank increased its position in Brunswick Corporation by 5.6% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 6,437 shares of the company’s stock worth $314,000 after buying an additional 342 shares in the last quarter. 99.34% of the stock is owned by institutional investors.

Flinton Capital Management LLC acquired a new position in shares of Brunswick Corporation (NYSE:BC) during the fourth quarter, Holdings Channel reports. The institutional investor acquired 7,448 shares of the company’s stock, valued at approximately $406,000.

Brunswick Corporation (NYSE:BC) traded up 0.79% during mid-day trading on Friday, reaching $60.61. 239,006 shares of the company were exchanged. The stock’s 50-day moving average is $58.12 and its 200-day moving average is $51.10. Brunswick Corporation has a 12 month low of $41.19 and a 12 month high of $61.24. The company has a market cap of $5.43 billion, a P/E ratio of 20.22 and a beta of 1.95.

Brunswick Corporation (NYSE:BC) last released its quarterly earnings results on Thursday, January 26th. The company reported $0.67 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.65 by $0.02. Brunswick Corporation had a return on equity of 23.22% and a net margin of 6.15%. The business earned $1.08 billion during the quarter, compared to analyst estimates of $1.11 billion. During the same quarter last year, the company posted $0.52 EPS. Brunswick Corporation’s revenue for the quarter was up 9.8% on a year-over-year basis. Equities analysts expect that Brunswick Corporation will post $4.01 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, March 15th. Investors of record on Tuesday, February 28th will be given a $0.165 dividend. The ex-dividend date of this dividend is Friday, February 24th. This represents a $0.66 dividend on an annualized basis and a dividend yield of 1.09%. Brunswick Corporation’s dividend payout ratio (DPR) is 22.07%.

A number of research firms have recently commented on BC. B. Riley reaffirmed a “buy” rating and set a $65.00 price objective on shares of Brunswick Corporation in a research note on Wednesday, November 2nd. Zacks Investment Research raised shares of Brunswick Corporation from a “sell” rating to a “hold” rating in a research note on Monday, October 31st. Wedbush upped their price objective on shares of Brunswick Corporation from $60.00 to $66.00 and gave the company an “outperform” rating in a research note on Friday, December 16th. Jefferies Group LLC reaffirmed a “hold” rating on shares of Brunswick Corporation in a research note on Tuesday, January 3rd. Finally, Royal Bank of Canada upped their price objective on shares of Brunswick Corporation from $57.00 to $65.00 and gave the company an “outperform” rating in a research note on Friday, January 27th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and eleven have given a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus target price of $63.08.

In related news, VP Christopher F. Dekker sold 1,645 shares of the stock in a transaction on Monday, February 6th. The stock was sold at an average price of $60.33, for a total value of $99,242.85. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider John C. Pfeifer sold 2,878 shares of the stock in a transaction on Wednesday, February 8th. The shares were sold at an average price of $59.63, for a total value of $171,615.14. Following the completion of the transaction, the insider now owns 40,514 shares of the company’s stock, valued at approximately $2,415,849.82. The disclosure for this sale can be found here. Insiders sold a total of 23,716 shares of company stock valued at $1,325,513 in the last quarter. 2.50% of the stock is currently owned by corporate insiders.

Brunswick Corporation Company Profile

Brunswick Corporation (Brunswick) is a designer, manufacturer and marketer of recreation products, including marine engines, boats, fitness and active recreation products. The Company operates in three segments, which include Marine Engine, Boat and Fitness. The Marine Engine segment manufactures and markets a range of outboard engines, sterndrive engines, inboard engines and marine parts and accessories, which are principally sold directly to boat builders, including Brunswick’s Boat segment, or through marine retail dealers and distributors across the world.

Want to see what other hedge funds are holding BC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Brunswick Corporation (NYSE:BC).

The Flinton Capital Management LLC Buys Shares of 6,222 W.R. Berkley Corporation (WRB)

Other hedge funds have also recently modified their holdings of the company. TD Asset Management Inc. increased its stake in shares of W.R. Berkley Corporation by 3.7% in the third quarter. TD Asset Management Inc. now owns 638,268 shares of the company’s stock valued at $36,866,000 after buying an additional 22,904 shares in the last quarter. BlackRock Inc. increased its stake in shares of W.R. Berkley Corporation by 5.0% in the third quarter. BlackRock Inc. now owns 187,405 shares of the company’s stock valued at $10,824,000 after buying an additional 8,974 shares in the last quarter. Dean Investment Associates LLC increased its stake in shares of W.R. Berkley Corporation by 1.3% in the third quarter. Dean Investment Associates LLC now owns 9,212 shares of the company’s stock valued at $532,000 after buying an additional 117 shares in the last quarter. Korea Investment CORP increased its stake in shares of W.R. Berkley Corporation by 7.5% in the third quarter. Korea Investment CORP now owns 98,900 shares of the company’s stock valued at $5,712,000 after buying an additional 6,900 shares in the last quarter. Finally, California State Teachers Retirement System increased its stake in shares of W.R. Berkley Corporation by 0.9% in the third quarter. California State Teachers Retirement System now owns 210,342 shares of the company’s stock valued at $12,149,000 after buying an additional 1,800 shares in the last quarter. Institutional investors own 71.79% of the company’s stock.

Flinton Capital Management LLC bought a new stake in shares of W.R. Berkley Corporation (NYSE:WRB) during the fourth quarter, Holdings Channel reports. The institutional investor bought 6,222 shares of the company’s stock, valued at approximately $414,000.

W.R. Berkley Corporation (NYSE:WRB) traded down 0.06% during trading on Friday, reaching $71.52. The company’s stock had a trading volume of 104,283 shares. W.R. Berkley Corporation has a one year low of $51.50 and a one year high of $71.68. The firm has a market cap of $8.67 billion, a PE ratio of 15.28 and a beta of 0.73. The company has a 50-day moving average of $68.06 and a 200 day moving average of $61.83.

W.R. Berkley Corporation (NYSE:WRB) last issued its quarterly earnings data on Tuesday, January 31st. The company reported $0.82 EPS for the quarter, beating the consensus estimate of $0.78 by $0.04. The firm earned $1.97 billion during the quarter, compared to the consensus estimate of $1.89 billion. W.R. Berkley Corporation had a net margin of 7.86% and a return on equity of 8.93%. The company’s quarterly revenue was up 8.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.85 earnings per share. Analysts expect that W.R. Berkley Corporation will post $3.40 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 5th. Stockholders of record on Wednesday, March 15th will be paid a dividend of $0.13 per share. This represents a $0.52 annualized dividend and a dividend yield of 0.73%. The ex-dividend date of this dividend is Monday, March 13th. W.R. Berkley Corporation’s dividend payout ratio (DPR) is 11.06%.

WRB has been the subject of several research reports. Goldman Sachs Group, Inc. (The) downgraded W.R. Berkley Corporation from a “buy” rating to a “neutral” rating and set a $60.00 target price for the company. in a research note on Tuesday, November 15th. Zacks Investment Research downgraded W.R. Berkley Corporation from a “buy” rating to a “hold” rating in a research note on Thursday, October 27th. Macquarie upgraded W.R. Berkley Corporation from an “underperform” rating to an “outperform” rating in a research note on Tuesday, January 17th. Finally, Langen Mcalenn reiterated a “neutral” rating on shares of W.R. Berkley Corporation in a research note on Tuesday, January 31st. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and one has given a buy rating to the company’s stock. W.R. Berkley Corporation currently has an average rating of “Hold” and an average price target of $61.17.

W.R. Berkley Corporation Company Profile

W. R. Berkley Corporation is an insurance holding company. The Company operates in the three segments of the property casualty insurance business: Insurance-Domestic, Insurance-International and Reinsurance-Global. Its Insurance-Domestic segment includes commercial insurance business, including excess and surplus lines and admitted lines, primarily throughout the United States.

Want to see what other hedge funds are holding WRB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for W.R. Berkley Corporation (NYSE:WRB).

The Flinton Capital Management LLC Buys New Position in Proofpoint, Inc. (PFPT)

A number of other large investors also recently modified their holdings of PFPT. FNY Partners Fund LP bought a new stake in shares of Proofpoint during the fourth quarter valued at $141,000. BlackRock Japan Co. Ltd raised its stake in shares of Proofpoint by 360.2% in the third quarter. BlackRock Japan Co. Ltd now owns 1,919 shares of the company’s stock valued at $144,000 after buying an additional 1,502 shares in the last quarter. BOKF NA raised its stake in shares of Proofpoint by 2.4% in the third quarter. BOKF NA now owns 3,126 shares of the company’s stock valued at $234,000 after buying an additional 73 shares in the last quarter. Tocqueville Asset Management L.P. bought a new stake in shares of Proofpoint during the third quarter valued at $299,000. Finally, BNP Paribas Arbitrage SA raised its stake in shares of Proofpoint by 71.9% in the third quarter. BNP Paribas Arbitrage SA now owns 4,156 shares of the company’s stock valued at $311,000 after buying an additional 1,739 shares in the last quarter.

Flinton Capital Management LLC bought a new stake in Proofpoint, Inc. (NASDAQ:PFPT) during the fourth quarter, Holdings Channel reports. The firm bought 6,000 shares of the company’s stock, valued at approximately $424,000.

Shares of Proofpoint, Inc. (NASDAQ:PFPT) traded down 1.52% on Friday, reaching $80.08. The company had a trading volume of 209,282 shares. Proofpoint, Inc. has a one year low of $46.37 and a one year high of $88.00. The firm’s market cap is $3.44 billion. The company has a 50-day moving average price of $80.91 and a 200-day moving average price of $76.91.

Proofpoint (NASDAQ:PFPT) last announced its quarterly earnings results on Thursday, January 26th. The company reported $0.18 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.13 by $0.05. The business had revenue of $106.80 million for the quarter, compared to analyst estimates of $104.81 million. Proofpoint had a negative return on equity of 110.22% and a negative net margin of 29.62%. Proofpoint’s quarterly revenue was up 42.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned ($0.11) EPS. On average, analysts expect that Proofpoint, Inc. will post $0.52 earnings per share for the current fiscal year.

Several equities research analysts have weighed in on the company. Imperial Capital increased their target price on Proofpoint from $85.00 to $100.00 and gave the stock an “outperform” rating in a research report on Sunday, January 29th. Needham & Company LLC reaffirmed a “buy” rating and issued a $88.00 target price on shares of Proofpoint in a research report on Wednesday, December 21st. Zacks Investment Research lowered Proofpoint from a “buy” rating to a “hold” rating in a research report on Thursday, December 22nd. Robert W. Baird assumed coverage on Proofpoint in a research report on Monday, November 14th. They issued an “outperform” rating and a $92.00 target price on the stock. Finally, BTIG Research reaffirmed a “buy” rating on shares of Proofpoint in a research report on Tuesday, January 24th. Three research analysts have rated the stock with a hold rating and twenty-three have given a buy rating to the company. The stock currently has an average rating of “Buy” and an average price target of $83.50.

In related news, Chairman Eric Hahn sold 5,000 shares of the business’s stock in a transaction on Wednesday, December 21st. The stock was sold at an average price of $70.46, for a total value of $352,300.00. Following the sale, the chairman now owns 121,215 shares of the company’s stock, valued at approximately $8,540,808.90. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP David Knight sold 3,000 shares of the business’s stock in a transaction on Thursday, December 15th. The shares were sold at an average price of $72.12, for a total value of $216,360.00. Following the completion of the sale, the executive vice president now directly owns 8,889 shares in the company, valued at approximately $641,074.68. The disclosure for this sale can be found here. In the last ninety days, insiders sold 91,935 shares of company stock worth $6,987,370. 6.80% of the stock is owned by insiders.

Proofpoint Company Profile

Proofpoint, Inc is a security-as-a-service provider that enables large and mid-sized organizations around the world. The Company’s security-as-a-service platform consists of a suite of on-demand data protection solutions, including threat protection, incident response, regulatory compliance, archiving, governance, eDiscovery and secure communication.

Want to see what other hedge funds are holding PFPT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Proofpoint, Inc. (NASDAQ:PFPT).

The New Residential Investment Corp. (NRZ) PT Raised to $17.50 at FBR & Co

Several other brokerages also recently weighed in on NRZ. Zacks Investment Research downgraded New Residential Investment Corp. from a “buy” rating to a “hold” rating in a research report on Thursday, January 5th. Keefe, Bruyette & Woods reiterated an “outperform” rating on shares of New Residential Investment Corp. in a research report on Monday, February 6th. Compass Point upgraded New Residential Investment Corp. from a “neutral” rating to a “buy” rating in a research report on Tuesday, January 31st. Barclays PLC set a $16.00 price objective on New Residential Investment Corp. and gave the company a “buy” rating in a research report on Saturday, November 19th. Finally, TheStreet raised New Residential Investment Corp. from a “hold” rating to a “buy” rating in a research note on Tuesday, November 15th. One equities research analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus target price of $16.32.

New Residential Investment Corp. (NYSE:NRZ) had its price target increased by stock analysts at FBR & Co from $16.75 to $17.50 in a research note issued to investors on Wednesday. The firm presently has an “outperform” rating on the real estate investment trust’s stock. FBR & Co’s price target would indicate a potential upside of 5.04% from the company’s previous close.

New Residential Investment Corp. (NYSE:NRZ) opened at 16.66 on Wednesday. The company has a market capitalization of $4.18 billion, a PE ratio of 10.17 and a beta of 0.96. The firm’s 50-day moving average price is $16.02 and its 200 day moving average price is $14.95. New Residential Investment Corp. has a 52 week low of $10.30 and a 52 week high of $16.78.

New Residential Investment Corp. (NYSE:NRZ) last announced its quarterly earnings data on Tuesday, February 21st. The real estate investment trust reported $0.62 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.55 by $0.07. New Residential Investment Corp. had a return on equity of 15.13% and a net margin of 38.93%. During the same period in the prior year, the company earned $0.52 earnings per share. Equities research analysts expect that New Residential Investment Corp. will post $2.11 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 28th. Stockholders of record on Monday, March 27th will be paid a dividend of $0.48 per share. This is a boost from New Residential Investment Corp.’s previous quarterly dividend of $0.46. This represents a $1.92 annualized dividend and a dividend yield of 11.52%. New Residential Investment Corp.’s payout ratio is 112.20%.

In other New Residential Investment Corp. news, CEO Michael Nierenberg bought 18,600 shares of New Residential Investment Corp. stock in a transaction dated Friday, February 3rd. The shares were purchased at an average cost of $15.00 per share, with a total value of $279,000.00. Following the completion of the purchase, the chief executive officer now owns 935,352 shares of the company’s stock, valued at $14,030,280. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 4.00% of the stock is currently owned by insiders.

Institutional investors have recently bought and sold shares of the stock. NEXT Financial Group Inc boosted its position in New Residential Investment Corp. by 19.3% in the third quarter. NEXT Financial Group Inc now owns 7,410 shares of the real estate investment trust’s stock valued at $102,000 after buying an additional 1,201 shares during the period. Baldwin Brothers Inc. MA acquired a new position in New Residential Investment Corp. during the third quarter valued at about $110,000. Public Employees Retirement System of Ohio boosted its position in New Residential Investment Corp. by 19.8% in the second quarter. Public Employees Retirement System of Ohio now owns 10,857 shares of the real estate investment trust’s stock valued at $150,000 after buying an additional 1,798 shares during the period. FNY Partners Fund LP acquired a new position in New Residential Investment Corp. during the fourth quarter valued at about $157,000. Finally, Commerzbank Aktiengesellschaft FI acquired a new position in New Residential Investment Corp. during the fourth quarter valued at about $164,000. 46.29% of the stock is currently owned by hedge funds and other institutional investors.

New Residential Investment Corp. Company Profile

New Residential Investment Corp. is a real estate investment trust (REIT). The Company is focused on investing in, and managing, investments related to residential real estate. The Company conducts its business through the segments, which include investments in excess mortgage servicing rights (MSRs), investments in servicer advances, investments in real estate securities, investments in real estate loans, investments in consumer loans and corporate.

The Enel Americas SA’s (ENI) Buy Rating Reiterated at Goldman Sachs Group, Inc. (The)

Shares of Enel Americas SA (NYSE:ENI) opened at 13.76 on Tuesday. The company’s 50 day moving average is $13.67 and its 200-day moving average is $12.66. Enel Americas SA has a 52 week low of $10.33 and a 52 week high of $18.72.

Goldman Sachs Group, Inc. (The) reiterated their buy rating on shares of Enel Americas SA (NYSE:ENI) in a report issued on Tuesday.

Enel Americas SA Company Profile

Enel Americas SA, formerly Enersis Americas SA, through its subsidiaries and jointly controlled entities, is engaged in the electricity generation, transmission and distribution businesses in Chile, Brazil, Colombia, Peru and Argentina. The Company operates through two segments: Generation and Transmission, and Distribution.

The OncoCyte Corp (OCX) Now Covered by Analysts at Chardan Capital

Separately, Canaccord Genuity reiterated a buy rating on shares of OncoCyte Corp in a report on Monday, January 30th.

Chardan Capital began coverage on shares of OncoCyte Corp (AMEX:OCX) in a research report sent to investors on Thursday, StockTargetPrices.com reports. The firm issued a buy rating and a $6.50 price target on the stock.

OncoCyte Corp (AMEX:OCX) traded up 2.38% during mid-day trading on Thursday, reaching $5.10. The company’s stock had a trading volume of 4,801 shares. OncoCyte Corp has a 52 week low of $3.10 and a 52 week high of $7.95. The firm’s market capitalization is $146.42 million. The company’s 50-day moving average price is $5.79 and its 200 day moving average price is $5.23.

OncoCyte Corp Company Profile

OncoCyte Corporation is a development-stage biotechnology company focused in the field of regenerative medicine. The Company is developing molecular cancer diagnostics utilizing a discovery platform that focuses on identifying genetic markers expressed in various types of cancer. It operates through the research and development of diagnostic tests for the detection of cancer segment.

The Orange SA (ORA) Given a €16.50 Price Target by Kepler Capital Markets Analysts

A number of other research firms have also weighed in on ORA. HSBC Holdings plc set a €17.00 ($18.09) price target on shares of Orange SA and gave the company a buy rating in a report on Monday, January 16th. J P Morgan Chase & Co reaffirmed a buy rating on shares of Orange SA in a report on Friday, January 6th. Morgan Stanley set a €20.50 ($21.81) price target on shares of Orange SA and gave the company a buy rating in a report on Tuesday. S&P Global set a €17.00 ($18.09) price target on shares of Orange SA and gave the company a buy rating in a report on Thursday. Finally, Goldman Sachs Group, Inc. (The) set a €20.50 ($21.81) price target on shares of Orange SA and gave the company a buy rating in a report on Tuesday. Three analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. Orange SA has a consensus rating of Buy and a consensus price target of €17.55 ($18.67).

Kepler Capital Markets set a €16.50 ($17.55) price target on Orange SA (EPA:ORA) in a research note published on Thursday. The firm currently has a buy rating on the stock.

Orange SA (EPA:ORA) traded down 1.30% on Thursday, reaching €14.42. 7,580,534 shares of the company’s stock were exchanged. The firm has a market capitalization of €38.35 billion and a price-to-earnings ratio of 8.38. Orange SA has a 1-year low of €12.38 and a 1-year high of €16.63. The stock’s 50 day moving average price is €14.57 and its 200 day moving average price is €14.01.

About Orange SA

Orange SA is a telecommunications operator. The Company also provides telecommunication services to multinational companies, under the brand Orange Business Services. The Company’s segments include France, Spain, Poland, Belgium and Luxembourg, Central European countries, Africa and Middle East, Enterprise, and International Carriers & Shared Services.